L. Roy Papp & Associates LLP Has $979,000 Holdings in Silicon Laboratories Inc. (NASDAQ:SLAB)

L. Roy Papp & Associates LLP reduced its stake in shares of Silicon Laboratories Inc. (NASDAQ:SLAB) by 4.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,700 shares of the semiconductor company’s stock after selling 440 shares during the quarter. L. Roy Papp & Associates LLP’s holdings in Silicon Laboratories were worth $979,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Jones Financial Companies Lllp raised its stake in Silicon Laboratories by 44.5% during the 4th quarter. Jones Financial Companies Lllp now owns 224 shares of the semiconductor company’s stock valued at $28,000 after purchasing an additional 69 shares during the last quarter. Parallel Advisors LLC increased its holdings in Silicon Laboratories by 143.7% in the 1st quarter. Parallel Advisors LLC now owns 463 shares of the semiconductor company’s stock valued at $52,000 after buying an additional 273 shares during the period. Headlands Technologies LLC bought a new stake in Silicon Laboratories in the 4th quarter valued at $70,000. Venturi Wealth Management LLC increased its holdings in Silicon Laboratories by 207.0% in the 4th quarter. Venturi Wealth Management LLC now owns 786 shares of the semiconductor company’s stock valued at $98,000 after buying an additional 530 shares during the period. Finally, Asset Management One Co. Ltd. bought a new stake in Silicon Laboratories in the 4th quarter valued at $117,000.

Analyst Ratings Changes

Several brokerages have issued reports on SLAB. Wall Street Zen raised shares of Silicon Laboratories from a “sell” rating to a “hold” rating in a report on Wednesday, May 14th. Susquehanna boosted their price target on shares of Silicon Laboratories from $100.00 to $110.00 and gave the company a “neutral” rating in a report on Wednesday, May 14th. Stifel Nicolaus lowered their price target on shares of Silicon Laboratories from $145.00 to $120.00 and set a “buy” rating on the stock in a report on Thursday, April 17th. Needham & Company LLC reissued a “buy” rating and issued a $150.00 price target on shares of Silicon Laboratories in a report on Wednesday, May 14th. Finally, Benchmark reissued a “buy” rating and issued a $160.00 price target on shares of Silicon Laboratories in a report on Tuesday, May 27th. Four research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $126.50.

Silicon Laboratories Stock Performance

SLAB opened at $125.33 on Thursday. The firm’s 50-day simple moving average is $109.06 and its 200-day simple moving average is $122.51. Silicon Laboratories Inc. has a twelve month low of $82.82 and a twelve month high of $160.00. The firm has a market cap of $4.08 billion, a price-to-earnings ratio of -21.10 and a beta of 1.36.

Silicon Laboratories (NASDAQ:SLAB) last posted its earnings results on Tuesday, May 13th. The semiconductor company reported ($0.08) earnings per share for the quarter, topping the consensus estimate of ($0.09) by $0.01. Silicon Laboratories had a negative net margin of 32.69% and a negative return on equity of 10.46%. The business had revenue of $177.71 million for the quarter, compared to analyst estimates of $177.48 million. During the same quarter in the prior year, the firm earned ($0.92) EPS. The firm’s quarterly revenue was up 67.0% compared to the same quarter last year. As a group, sell-side analysts anticipate that Silicon Laboratories Inc. will post -0.97 EPS for the current fiscal year.

Insider Transactions at Silicon Laboratories

In related news, CEO Robert Matthew Johnson sold 5,879 shares of the company’s stock in a transaction dated Friday, May 16th. The shares were sold at an average price of $131.20, for a total transaction of $771,324.80. Following the transaction, the chief executive officer now owns 73,688 shares in the company, valued at $9,667,865.60. This represents a 7.39% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Christy Wyatt sold 546 shares of the company’s stock in a transaction dated Tuesday, May 6th. The stock was sold at an average price of $104.45, for a total transaction of $57,029.70. Following the transaction, the director now owns 8,492 shares in the company, valued at approximately $886,989.40. This trade represents a 6.04% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 11,626 shares of company stock valued at $1,509,319. 1.60% of the stock is owned by insiders.

About Silicon Laboratories

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.